Clinical Trial Update: 68Ga-BNOTA-PRGD2 PET/CT in Healthy Volunteers and Lung Cancer Patients [EARLY_Phase 1]

View source ↗

Summary

This early Phase 1 trial evaluates the radiotracer 68Ga-BNOTA-PRGD2 with PET/CT in healthy volunteers and lung cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• 68Ga-BNOTA-PRGD2

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Lung Cancer | EARLY_Phase 1 | Status: UNKNOWN